Cadrenal Therapeutics Inc. Common Stock (CVKD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cadrenal Therapeutics Inc...

    NASDAQ: CVKD · Real-Time Price · USD
    13.25
    0.16 (1.22%)
    At close: Sep 10, 2025, 3:59 PM
    14.00
    5.66%
    After-hours: Sep 10, 2025, 06:33 PM EDT

    Cadrenal Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 1.88K 1.98K 1.27K
    Gross Profit
    		 -1.88K -1.98K -1.27K
    Operating Income
    		 -10.96M -7.63M -2.7M
    Interest Income
    		 309.25K 249.09K n/a
    Pretax Income
    		 -10.65M -8.36M -6.71M
    Net Income
    		 -10.65M -8.36M -6.71M
    Selling & General & Admin
    		 6.75M 3.55M 2.31M
    Research & Development
    		 4.21M 4.08M 392.86K
    Other Expenses
    		 1.88K n/a n/a
    Operating Expenses
    		 10.96M 7.63M 2.7M
    Interest Expense
    		 n/a 17.1K 107.11K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 10.96M 7.63M 2.7M
    Income Tax Expense
    		 n/a n/a 4.00
    Shares Outstanding (Basic)
    		 1.22M 868.18K 775.64K
    Shares Outstanding (Diluted)
    		 1.22M 868.18K 775.64K
    EPS (Basic)
    		 -8.73 -9.63 -8.66
    EPS (Diluted)
    		 -8.73 -9.63 -8.66
    EBITDA
    		 -10.65M -8.34M -6.61M
    EBIT
    		 -10.65M -8.34M -6.61M
    Depreciation & Amortization
    		 1.88K 1.98K 1.27K

    Add to Watchlist